Join to view full profile
315 7th StNew Kensington, PA 15068
Phone+1 724-337-6232
Fax+1 724-337-6721
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Reilly, MD is an internist in New Kensington, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
University of Pittsburgh Medical Center Medical EducationFellowship, Cardiovascular Disease, 1986 - 1989- UPMC Medical EducationResidency, Internal Medicine, 1983 - 1986
- UPMC Medical Education (Presbyterian Shadyside Hospital)Internship, Transitional Year, 1982 - 1983
Manila Central University College of MedicineClass of 1981
Certifications & Licensure
PA State Medical License 1983 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- 94 citationsDabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.Jacqueline Halton, Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars, Elizabeth Chalmers
The Lancet. Haematology. 2021-01-01 - 9 citationsProfile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.Samuel Z. Goldhaber, Walter Ageno, Ivan Benaduce Casella, Kok Han Chee, Sebastian Schellong
The American Journal of Medicine. 2020-08-01 - 34 citationsGlobal Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance ProgramJohn Fanikos, Debra Murwin, Fredrik Gruenenfelder, Igor Tartakovsky, Lionel Riou França
Thrombosis and Haemostasis. 2020-01-01
